Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gerson

Showing results (161-170 of 257) with videos related to

Pageof 26
Sort By:
Mutation Research|June 1, 1994
Alkyltransferase transgenic mice: probes of chemical carcinogenesisS L Gerson, N H Zaidi, L L Dumenco, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2011
Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux diseaseT Hershcovici, L K Jha, T Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosoureaJ S Reese, O N Koç, K M Lee, et al.
Oncotarget|August 13, 2016
Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damageYan Yan, Xiangzi Han, Yulan Qing, et al.
Gene Therapy|July 31, 2004
Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selectionE Richard, E Robert, M Cario-André, et al.
Cancer Chemotherapy and Pharmacology|March 14, 2007
O6-benzylguanine and BCNU in multiple myeloma: a phase II trialEric D Batts, Christopher Maisel, Donna Kane, et al.
Plos One|May 25, 2012
Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammationMichael O Alberti, Justin C Roth, Mourad Ismail, et al.
Stem Cells Translational Medicine|April 16, 2018
MMR Deficiency Does Not Sensitize or Compromise the Function of Hematopoietic Stem Cells to Low and High LET RadiationRutulkumar Patel, Yulan Qing, Lucy Kennedy, et al.
Plos One|December 17, 2008
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissuesEduardo K Moioli, Paul A Clark, Mo Chen, et al.
Carcinogenesis|May 1, 1995
The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgeneN H Zaidi, E Allay, T C Ayi, et al.
Pageof 26

Showing results (161-170 of 257) with videos related to

Sort By:
Pageof 26
Mutation Research|June 1, 1994
Alkyltransferase transgenic mice: probes of chemical carcinogenesisS L Gerson, N H Zaidi, L L Dumenco, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2011
Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux diseaseT Hershcovici, L K Jha, T Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Retroviral transduction of a mutant methylguanine DNA methyltransferase gene into human CD34 cells confers resistance to O6-benzylguanine plus 1,3-bis(2-chloroethyl)-1-nitrosoureaJ S Reese, O N Koç, K M Lee, et al.
Oncotarget|August 13, 2016
Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damageYan Yan, Xiangzi Han, Yulan Qing, et al.
Gene Therapy|July 31, 2004
Hematopoietic stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selectionE Richard, E Robert, M Cario-André, et al.
Cancer Chemotherapy and Pharmacology|March 14, 2007
O6-benzylguanine and BCNU in multiple myeloma: a phase II trialEric D Batts, Christopher Maisel, Donna Kane, et al.
Plos One|May 25, 2012
Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammationMichael O Alberti, Justin C Roth, Mourad Ismail, et al.
Stem Cells Translational Medicine|April 16, 2018
MMR Deficiency Does Not Sensitize or Compromise the Function of Hematopoietic Stem Cells to Low and High LET RadiationRutulkumar Patel, Yulan Qing, Lucy Kennedy, et al.
Plos One|December 17, 2008
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissuesEduardo K Moioli, Paul A Clark, Mo Chen, et al.
Carcinogenesis|May 1, 1995
The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgeneN H Zaidi, E Allay, T C Ayi, et al.
Pageof 26